Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gynecological Cancers × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 23 Lymphoma 17 Recurrence 3 Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Vulvar Neoplasms 2 Testicular Neoplasms 2 Neoplasms, Germ Cell and Embryonal 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Follicular 2 Head and Neck Neoplasms 2 HIV Infections 2 Dendritic Cell Sarcoma, Interdigitating 2 Burkitt Lymphoma 2 Acquired Immunodeficiency Syndrome 2 Waldenstrom Macroglobulinemia 1 Ulcer 1 Testicular Germ Cell Tumor 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sertoli-Leydig Cell Tumor 1 Seminoma 1 Sarcoma, Kaposi 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Processes 1 Ovarian gynandroblastoma 1 Neoplastic Processes 1 Neoplasms, Plasma Cell 1

Interventions

Pharmaceutical Preparations 1 Electroporation 1 Electrochemotherapy 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04760327 2024-10-17

GynECT

Institute of Oncology Ljubljana

Phase 2 Recruiting

Gynecological Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡